Back to search

Article

Multi-compartment immune and tumor cell reprogramming by IFNα2 overcomes colon cancer immunotherapy resistance

2026-07-01

Abstract excerpt

<h4>SUMMARY</h4> Tumor cell PD-L1 represses IFN signaling to limit anti-tumor immunity, despite an IFN-responsive immunophenotype predicting colorectal cancer response to immune checkpoint inhibitor therapy. Lipid nanoparticle (LNP)-encapsulated IFNα2-encoding nanoplasmid (LNP-mIFNα2) gene therapy suppresses tumor progression, however, the underlying mechanism and therapeutic trade-offs of the accompanying proinf...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dc9b9852-8a1a-526f-b991-1f46efc18e75
DOI
10.64898/2026.06.26.734809
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Multi-compartment immune and tumor cell reprogramming by IFNα2 overcomes colon cancer immunotherapy resistanceDOI 10.64898/2026.06.26.734809
Select a neighboring publication to make it the new centre.